Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Filings indexed 1,662 across all filing types
Latest filing 2026-01-21 Capital/Financing Update
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Prospectus Supplement 71 pages 646.5KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Prospectus Supplement' and includes detailed information about a public offering of common stock, including the number of shares, pricing, underwriting details, and legal disclaimers. It references filing with the U.S. Securities and Exchange Commission (SEC) and includes a registration statement number. The content focuses on the terms of a securities offering and related private placement, which is characteristic of capital raising activities. There is no indication of financial statements, audit reports, management discussions, or other report types. The document is lengthy (15,000 characters) and contains substantive information about the offering, not merely an announcement or a brief summary. Therefore, the document fits the category of a Capital/Financing Update, which covers company fundraising and financing activities.
2026-01-21 English
FWP
Regulatory Filings
2026-01-21 English
FWP
Regulatory Filings
2026-01-20 English
424B5
Regulatory Filings
2026-01-20 English
Proposed $US200m Offering & Medtronic Strategic Investment 3 pages 188.3KB
Capital/Financing Update Classification · 95% confidence The document is an announcement by Anteris Technologies Global Corp. regarding a proposed $200 million public offering of common stock and a strategic investment from Medtronic. It details the terms of the offering, the private placement, use of proceeds, underwriters, and regulatory filings related to the offering (Form S-3 Registration Statement). The document is primarily a capital raising update and does not contain financial statements or detailed financial performance data. It is not a full annual or interim report, nor an earnings release or management discussion. The content fits the definition of a Capital/Financing Update (CAP) as it provides information on fundraising and capital structure changes. The document length (9607 characters) is sufficient to be more than a brief announcement but it is clearly focused on financing activities. Therefore, the appropriate classification is CAP with high confidence.
2026-01-20 English
Trading Halt 2 pages 309.4KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from Anteris Technologies Global Corp regarding a trading halt requested pending the release of an announcement related to the pricing of a proposed capital raising. It is a short notice about the trading halt and does not contain any financial statements or detailed report data. The document is essentially an announcement about a trading halt due to an upcoming capital raising announcement, not the capital raising update itself. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to financing activities, specifically a capital raising event.
2026-01-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.